GL1X · GenesisL1 explorer

MolNFT v1 · #126320 · protein

Fragment-based inhibitors of lipoprotein associated phospholipase A2

5LZ5: “Fragment-based inhibitors of lipoprotein associated phospholipase A2”. X-ray diffraction, 2 ligands (7K4, CL). MolNFT v1 #126320 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5LZ5
Type
protein
Length
371 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q13093
Ligands
7K4, CL

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein371—Q13093

Ligands and binding sites

  • 7K4 · 2-fluoranyl-5-[2-[(4~{S})-4-methyl-2-oxidanylidene-4-phenyl-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5LZ5 · Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13093 · AlphaFold monomer V2.0 prediction for platelet-activating factor acetylhydrolase (Q13093) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.